Phosphatidylserine (PS) is a phospholipid concentrated in brain cell membranes. Trials from the 1980s–90s using bovine-cortex PS reported modest memory improvements in older adults with age-related decline and dementia — but that form left the market over mad-cow concerns, and today's products are soy- or sunflower-derived, a structurally different molecule mix with only a few small, inconsistent trials of its own. The FDA permits only a heavily qualified label claim, noting the evidence is limited. PS is well tolerated at 100 mg three times daily; insomnia and stomach upset occur at higher doses.
What phosphatidylserine is
Phosphatidylserine is a phospholipid — a fat-and-phosphate molecule — that makes up a few percent of brain cell membranes, clustered on their inner face where it participates in signalling, neurotransmitter release and the housekeeping of dying cells. The body synthesizes what it needs; diet (organ meats, fish, soy) adds a little.
The supplement logic was simple: membranes age, PS is membrane, feed the membrane. The history that followed is a case study in how evidence and product can quietly part company.
The bovine asterisk
The trials that built PS's reputation — 1980s–90s studies in older adults with age-associated memory impairment and in dementia, several placebo-controlled, showing modest improvements in memory and daily function at 300 mg/day — used BC-PS: phosphatidylserine extracted from cow brains. When bovine spongiform encephalopathy ("mad cow") made brain-derived products untenable in the 1990s, manufacturers switched to soy-derived PS (now also sunflower). The molecule family is similar; the attached fatty acids differ; and the trial record did not transfer. Soy-PS has since produced a few small trials in older adults with memory complaints — some positive on isolated measures, others null — and nothing of the size or consistency that would settle it.
The U.S. FDA, asked to approve a health claim, permitted only a qualified one, required to state that the supporting evidence is limited. That wording, on any label carrying it, is the most honest sentence in the brain aisle.
Evidence by use
The graphic above gives the ratings; in brief — age-related memory complaints: mixed-but-interesting for a discontinued form, insufficient for the form actually sold; dementia: old, small, transient effects, bovine form; exercise cortisol: small high-dose studies without meaningful performance outcomes; children's attention: a couple of small trials, not decision-grade. Ranked against the rest of the aisle in Do memory supplements work?
Doses studied
100 mg three times daily (300 mg/day) is the classic regimen from the memory trials, taken with meals; sports studies ran 600–800 mg/day. Trials measured outcomes at 6–12 weeks.
Safety
One of the cleaner profiles in the category: at 300 mg/day, side effects hover at placebo levels; higher doses bring insomnia and stomach upset for some. Theoretical points — additive effects with cholinergic dementia drugs or anticholinergics, and a weak blood-thinning question — justify the standard mention to prescriber and pre-surgery pause. Soy-allergic users can seek sunflower-derived PS. Pregnancy: no data, avoid.
Where it appears in supplements
As a stand-alone (often soft-gels at 100 mg) and inside memory blends at 20–100 mg — token amounts of an ingredient whose trials, such as they are, used 300. The blend habit of borrowing an ingredient's reputation while abandoning its regimen is nowhere clearer than here, where even the reputation is borrowed from a different molecule. See brain supplement research.
Bottom line
PS is safe, cheap, and carries the supplement world's most instructive asterisk. An older adult who wants a low-risk 8–12-week experiment at the trialled 300 mg/day is running a reasonable one — with expectations set by the thin soy-form record, not the 1990s headlines. Anyone whose memory change is objective — noticed by others, touching function — needs the assessment that finds reversible causes, which no phospholipid provides.
Frequently asked questions
Is soy phosphatidylserine the same as the bovine version that was tested?
Chemically close but not identical — the fatty acids attached differ, and whether that matters for brain uptake is unresolved. What is certain is that the positive trial record belongs mostly to the bovine form, and the soy form cannot simply claim it.
What does the FDA's qualified claim actually say?
In essence: phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly, but the evidence is limited and inconclusive — wording the FDA requires precisely because the science does not support a confident claim. A qualified claim is a regulatory shrug, not an endorsement.
Is there any group where PS is worth trying?
The defensible experiment is an older adult with subjective memory complaints, 100 mg three times daily for 8–12 weeks with an honest before-and-after — the population and regimen closest to the old trials. Expectations should be set by the soy-form evidence, which is thin.
Does PS lower cortisol for athletes?
Small studies at 600–800 mg/day suggested blunted exercise cortisol responses; performance outcomes did not follow convincingly, and the doses are above the usual memory regimen.
References
- National Institute on Aging. Memory Problems, Forgetfulness, and Aging (2023). https://www.nia.nih.gov/health/memory-loss-and-forgetfulness/memory-problems-forgetfulness-and-aging
- National Center for Complementary and Integrative Health (NCCIH). Diabetes and Dietary Supplements: What You Need To Know (2021). https://www.nccih.nih.gov/health/diabetes-and-dietary-supplements-what-you-need-to-know
This page discusses supplement ingredients or categories. It may mention a commercial product, with disclosure. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.